Founded by scientists from University of California, San Diego in 2015, Genemo is a biotech company focusing on developing and driving the commercialization of a brand new RNA detection technology, which is going to shed light on disease diagnosis & therapeutics.
Staffed by top scientists and engineers from around the world, Genemo has developed a unique single-molecule fluorescent microscopy technology platform, Lucid RNA, which enables highly specific identification of RNA molecules at an extremely sensitive level. Genemo's core technology was exclusively licensed from University of California, San Diego.
Supporting its ambitious vision, Genemo's development team comprises a diverse set of talented individuals from backgrounds ranging from molecular biology, genetics, computer sciences, physics and electrical engineering. The board members and advisors come from academia and industry, each with a distinguished record. The work culture is founded on Genemo's core values of innovation, collaboration, responsibility, and openness.
Company Details
- Founded
- -
- Address
- 3210 Merryfield Row, San Diego,california 92121,united States
- in****@****emo.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.rnadiagnosis.com
- HQ
- San Diego, California
Genemo, Inc. Questions
Genemo, Inc.'s website is https://www.rnadiagnosis.com
Genemo, Inc.'s LinkedIn profile is https://www.linkedin.com/company/genemo
Genemo, Inc.'s industry is
Biotechnology Research
Genemo, Inc.'s top competitors are
Bristol Myers Squibb,
Outpace Bio,
Biocellion Spc,
Byterna Therapeutics,
Regeneron.
Genemo, Inc.'s support email address is info@genemo.com
Genemo, Inc.'s categories are Biotechnology Research
Genemo, Inc.'s founding year is 2015
